Emergent BioSolutions Inc.
EBS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367644
In the last 90 days, Emergent BioSolutions Inc. insiders filed 0 open-market purchases and 1 sale; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.
Superinvestors holding EBS, Q2 2026
No superinvestor reported holding EBS in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of EBS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+1,927.0%)
Q2 2021
1 superinvestor holding at quarter end